Myqif Myqif Myqif
Search Results
See All Results

    Join

    Sign In Sign Up
    Night Mode
    © 2026 Myqif
    About • CGU • Privacy • Directory

    Language

    English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek

Blogs

Discover Blogs

Groups

Discover Groups My Groups

Pages

Discover Pages Liked Pages

More

Popular Posts Discover Posts
Blogs Pages Groups
See All

Search

Discover new people, create new connections and make new friends

  • Posts
  • Articles
  • Users
  • Pages
  • Groups
  • Komal Galande added article News
    2026-03-16 06:12:23 ·
    Can Immune-Modulating Biologic Drugs Redefine Cancer Treatment Worldwide?
    Executive Summary Immune-Modulating Oncology Biologic Drugs Market Market Size and Share Analysis Report CAGR Value The global immune-modulating oncology biologic drugs market size was valued at USD 10.10 billion in 2025 and is expected to reach USD 28.54 billion by 2033, at a CAGR of13.87% during the forecast period   This Immune-Modulating...
    ·1971 Views
    Please log in to like, share and comment!
  • Komal Galande added article High-tech
    2025-12-30 09:04:07 ·
    Colorectal Cancer Treatment Market Advances with Targeted Therapies
    "Executive Summary Colorectal Cancer Treatment Market Size and Share: Global Industry Snapshot  Data Bridge Market Research analyses a growth rate in the colorectal cancer treatment market in the forecast period 2023-2030. The expected CAGR of colorectal cancer treatment market is tend to be around 4% in the mentioned forecast period. Research and analysis about the key...
    ·6075 Views
    Please log in to like, share and comment!
  • Komal Galande added article Sports
    2026-01-12 08:14:14 ·
    Erythropoietin Drugs Market Advances with Growing Demand for Anemia Therapies
    Executive Summary Erythropoietin (EPO) Drugs Market Size and Share Forecast The global erythropoietin (EPO) drugs market size was valued at USD 9.12 billion in 2024 and is expected to reach USD 22.60 billion by 2032, at a CAGR of 12.00% during the forecast period   The Erythropoietin (EPO) Drugs report also makes available CAGR value fluctuation...
    ·3492 Views
    Please log in to like, share and comment!